Labshake search
Citations for R&D Systems :
301 - 350 of 585 citations for Factor B Bb Blocking Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2020Quote: ... and 2.5 ng/µl of recombinant human fibroblast growth factor (R&D systems, Minneapolis, MN, USA), and cultured at 37°C in a humidified atmosphere of 5% CO2 in air ...
-
bioRxiv - Neuroscience 2023Quote: ... and human fibroblast growth factor 2 (hFGF2) (20 ng/mL, R&D systems 233-FB-025) freshly added into the media ...
-
bioRxiv - Genetics 2023Quote: ... 0.2% PrimocinTM and macrophage colony-stimulating factor (M-CSF) (20 ng/mL; R&D systems; USA) and receptor activator of nuclear factor kappa-B ligand (RANKL ...
-
bioRxiv - Cell Biology 2022Quote: ... but supplemented with 30ng/μl tumor necrosis factor alpha (TNFα; R&D systems, #210-TA-020) for 7d ...
-
bioRxiv - Cell Biology 2023Quote: ... 20 ng/mL glial cell line-derived neurotrophic factor (GDNF; R&D systems, catalog #: 212-GD), and 10 µM ROCK inhibitor Y27632 (HelloBio ...
-
bioRxiv - Genomics 2024Quote: ... 70% Feeder-CM plus 30% TS medium (70cond) supplemented with growth factor FGF4 (R&D System) and heparin (Sigma ...
-
bioRxiv - Neuroscience 2024Quote: ... and 2 ng/ml glial cell-derived neurotrophic factor (GDNF, R&D Systems, Minneapolis, MN, USA). The experiments were conducted on flasks or multi-well plates (Nunc ...
-
bioRxiv - Cell Biology 2024Quote: ... Then plated into Matrigel domes (Cultrex PathClear reduced growth factor BME, type 2; R&D Systems) in a 24 well plate ...
-
bioRxiv - Microbiology 2021Quote: ... goat polyclonal anti-cathepsin B (R&D Systems AF953; 1:800 dilution), goat polyclonal anti-cathepsin D (R&D Systems AF1014 ...
-
bioRxiv - Microbiology 2021Quote: ... Recombinant cathepsin B and cathepsin L were purchased from R&D Systems.
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant human TGF-β1 (#240-B) was purchased from R&D systems.
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant human TGF-β1 (#240-B) was from R&D Systems (UK) and used at a final concentration of 0.5 ng/ml ...
-
bioRxiv - Cell Biology 2022Quote: ... 10 ng/mL human recombinant activin B (R&D Systems, Minneapolis, MN), 0.1 nmol/L exendin-4 (Sigma) ...
-
bioRxiv - Neuroscience 2023Quote: ... goat anti-Wnt7a/b (1:1,000, R&D Systems, Cat# AF3460, RRID:AB_2304437), mouse Anti-beta Catenin (1:1,000 ...
-
bioRxiv - Immunology 2021Quote: ... Blocking of ACE2 was performed with 8 ug/mL anti-ACE2 (R&D systems) for 30 min at 37°C before adding stimuli ...
-
bioRxiv - Cancer Biology 2019Quote: ... Each well was supplemented with PDGFR-α blocking antibody (1:100; R&D Systems), or Imatinib (Seleckchem) ...
-
bioRxiv - Neuroscience 2021Quote: ... and incubated for 1 hour with blocking buffer (Reagent Diluent, R&D Systems, UK). Plates were washed 3 times with wash buffer and 100 ul of samples and standards were added (R&D Systems ...
-
bioRxiv - Systems Biology 2022Quote: ... avidin and biotin blocking reagents (HRP-DAB Cell &Tissue Staining Kit, R&D Systems) and washing in TBST in between each blocking step ...
-
bioRxiv - Neuroscience 2023Quote: cleaved caspase 3 (Cat. No. MAB835, 1:200 in blocking solution, R&D Systems), dsDNA (Cat No ...
-
bioRxiv - Neuroscience 2021Quote: ... The medium was supplemented with 20 ng/ml epidermal growth factor (EGF, #236-EG; R&D Systems) and 20 ng/ml basic fibroblast growth factor (bFGF ...
-
bioRxiv - Cancer Biology 2019Quote: ... medium was supplemented with a growth factor cocktail for recovery (100 ng/ml EGF (R&D Systems), 100 ng/ml FGF1 (R&D Systems) ...
-
bioRxiv - Bioengineering 2020Quote: ... resuspended in complete culture media supplemented with 0.25 μg/mL neural growth factor (NGF, R&D Systems) and 0.1 μg/mL Ciliary Neurotrophic Factor (CNTF ...
-
bioRxiv - Bioengineering 2020Quote: ... 2) transforming growth factor beta-2 (TGF-β2; 2.5 ng/ml; R&D Systems, Minneapolis, MN, USA), 3 ...
-
bioRxiv - Neuroscience 2019Quote: ... goat anti-platelet derived growth factor receptor-α (PDGFRα, 1:200, AF1062. R&D Systems, MN, USA), goat anti-Iba1 (1:200 ...
-
bioRxiv - Cell Biology 2021Quote: ... and the respective growth factors and small molecules (8 µM GSK-3 inhibitor CHIR99021 (R&D Systems), 200 ng/mL FGF9 (fibroblast growth factor 9 ...
-
bioRxiv - Molecular Biology 2022Quote: ... 10 ng/ml recombinant human brain-derived neurotrophic factor (BDNF) protein (R&D Systems 248-BDB-005), and 10 µM ɣ-secretase inhibitor (DAPT ...
-
bioRxiv - Microbiology 2023Quote: ... to promote M1-differentiation or 20 ng/ml macrophage colony-stimulating factor (M-CSF; R&D Systems) to promote M2-differentiation as previously described [9] ...
-
bioRxiv - Neuroscience 2023Quote: ... Recombinant mouse granulocyte-macrophage colony-stimulating factor (GM-CSF) was purchased from R&D systems (415ML/CF), recombinant human Interferon gamma1b (IFNγ1b ...
-
bioRxiv - Biochemistry 2023Quote: ... 20 ng/mL recombinant mouse tumor necrosis factor-α (TNF-α) (R&D Systems, 41-0MT0-25CF) and 12 ng/mL recombinant mouse IFN-γ were added to the media.
-
bioRxiv - Cancer Biology 2023Quote: ... All growth factors and most small molecules used for hESC differentiation were purchased from R&D Systems. ATRA ...
-
bioRxiv - Cancer Biology 2023Quote: ... Organoids were maintained in CultrexTM UltiMatrix Reduced Growth Factor Basement Membrane Extract (BME001-10, R&D Systems) and incubated in Advanced DMEM/F12 (12-634-010 ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) (50 ng/mL) (R&D Systems) and recombinant human interleukin-4 (IL-4 ...
-
bioRxiv - Cell Biology 2024Quote: ... and 125 ng/mL Fibroblast growth factor (FGF) -8b (423-F8-025/CF; R&D Systems Inc) to DPSC-BM as previously reported [35] ...
-
bioRxiv - Cell Biology 2021Quote: ... and 5 ng/mL TGF-β (R&D Systems, cat# 240-B-002). To test the effect of FYN depletion on collagen deposition ...
-
bioRxiv - Microbiology 2021Quote: ... 20μg of Anti IL28A/B (Clone 244716, MAB17892, R&D Systems, Minneapolis, MN) was infected intraperitoneally one day prior and each day following infection for the duration.
-
bioRxiv - Neuroscience 2022Quote: ... BoNT-B Light Chain (R&D Systems, cat #AF5420-SP, dilution 1:1000), VAMP2 (Synaptic Systems ...
-
bioRxiv - Neuroscience 2020Quote: ... Drugs used were as follows: rhTGFβ-1 (R&D Systems, #240-B-002), rhTGFβ-sRII (R&D Systems ...
-
bioRxiv - Cancer Biology 2019Quote: ... Cells were treated with 10ng/mL TGFB1 (R&D Systems, #240-B-010), 30ng/mL EGF (Invitrogen ...
-
bioRxiv - Molecular Biology 2022Quote: ... and buffered with 1X E3 Ligase Reaction Buffer (R&D systems, B-71). Substrates and Z-VAD-FMK (UBPBio ...
-
bioRxiv - Cell Biology 2022Quote: ... cells were stimulated with rhTGF-β1 (2ng/mL; R&D Systems; 240-B) for 24 hours ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were treated with RGDS peptide (10 μg/mL, R&D systems, MN, USA) (20 ...
-
Direct intracellular visualization of Ebola virus-receptor interaction by in situ proximity ligationbioRxiv - Microbiology 2020Quote: ... incubated with the fluorogenic peptide substrate Z-FR-AMC (150 μM; R&D Systems) and measured at a fluorometer following a 0 to 30 min incubation (ƛEx = 390 nm ...
-
bioRxiv - Neuroscience 2021Quote: ... insulin-like growth factor 1 (10 ng/mL; R&D Systems; Minneapolis, MN; Cat. No. 291-G1-200), brain-derived neurotrophic factor (10 ng/mL ...
-
bioRxiv - Biophysics 2020Quote: ... and differentiated into macrophages with 50 ng/mL granulocyte macrophage colony-stimulating factor (GM-CSF, R&D Systems) for 6d prior to infection.
-
bioRxiv - Molecular Biology 2022Quote: ... For cell treatment the following inhibitors and growth factors were used: FGF (R&D Systems, 233-FB-025), EGF (Sigma Aldrich ...
-
bioRxiv - Bioengineering 2019Quote: ... Cells were maintained in proliferating state using 10 ng/ml fibroblast growth factor 2 (FGF2; R&D Systems) and passaged twice before usage in the experiments ...
-
bioRxiv - Neuroscience 2020Quote: ... insulin-like growth factor 1 (10 ng/mL; R&D Systems; Minneapolis, MN; Cat. No. 291-G1-200), brain-derived neurotrophic factor (10 ng/mL ...
-
bioRxiv - Cancer Biology 2021Quote: ... This neural medium was supplemented with growth factors EGF (20 ng ml–1, R&D Systems, 236-EG) and FGF2 (20 ng ml–1 ...
-
bioRxiv - Immunology 2020Quote: ... CD14+ cells were differentiated with 20 ng/mL of macrophage colony-stimulating factor (M-CSF) (R&D systems) for 3 days followed by 3 days of polarization into naïve macrophages (M0 ...
-
bioRxiv - Biophysics 2023Quote: ... 10 ng/mL recombinant human transforming growth factor beta 1 (TGF-β1 from R&D System, Minnesota, USA). For 3D cultures ...